Millipore Sigma Vibrant Logo

371955 H-7, Dihydrochloride - CAS 108930-17-2 - Calbiochem

A broad-based, cell-permeable, reversible, ATP-competitive serine/threonine kinase inhibitor.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl

Primary Target: MLCK
371955
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

CAS #Empirical Formula
108930-17-2C₁₄H₁₇N₃O₂S · 2HCl

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
371955-1MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 1 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA broad-based, cell-permeable, reversible, ATP-competitive serine/threonine kinase inhibitor. Inhibits protein kinase A (Ki = 3.0 µM), myosin light chain kinase (Ki = 97 µM), protein kinase C (Ki = 6.0 µM), and protein kinase G (Ki = 5.8 µM). Induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells. Also inhibits telomerase activity in quercetin-, H-89-, or herbimycin A-treated NPC-076 cells.
      Catalogue Number371955
      Brand Family Calbiochem®
      Synonyms1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl
      References
      ReferencesKu, W.-C., et al. 1997. Biochem. Biophys. Res. Commun. 241, 730.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Bergstrand, H., et al. 1992. J. Pharmacol. Exp. Therap. 263, 1334.
      Gimond, C., et al. 1992. Exp. Cell Res. 203, 365.
      Quick, J., et al. 1992. Biochem. Biophys. Res. Commun. 187, 657.
      Bouli, N.M., and Davis, M. 1990. Brain Res. 525, 198.
      Takahashi, I., et al. 1990. J. Pharmacol. Exp. Ther. 255, 1218.
      Schachtele, C., et al. 1988. Biochem. Biophys. Res. Commun. 151, 542.
      Kawamoto, S., and Hidaka, H. 1984. Biochem. Biophys. Res. Commun. 125, 258.
      Product Information
      CAS number108930-17-2
      ATP CompetitiveY
      FormLight yellow lyophilized solid
      Hill FormulaC₁₄H₁₇N₃O₂S · 2HCl
      Chemical formulaC₁₄H₁₇N₃O₂S · 2HCl
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetMLCK
      Primary Target K<sub>i</sub>3.0 µM, 97 µM, 6.0 µM, 5.8 µM against protein kinase A , myosin light chain kinase, protein kinase C , and protein kinase G, respectively
      Purity≥98% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C). Aqueous stock solutions are stable for up to 6 months at 4°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      371955-1MG 04055977213485

      Documentation

      H-7, Dihydrochloride - CAS 108930-17-2 - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      H-7, Dihydrochloride - CAS 108930-17-2 - Calbiochem Certificados de análisis

      CargoNúmero de lote
      371955

      Referencias bibliográficas

      Visión general referencias
      Ku, W.-C., et al. 1997. Biochem. Biophys. Res. Commun. 241, 730.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Bergstrand, H., et al. 1992. J. Pharmacol. Exp. Therap. 263, 1334.
      Gimond, C., et al. 1992. Exp. Cell Res. 203, 365.
      Quick, J., et al. 1992. Biochem. Biophys. Res. Commun. 187, 657.
      Bouli, N.M., and Davis, M. 1990. Brain Res. 525, 198.
      Takahashi, I., et al. 1990. J. Pharmacol. Exp. Ther. 255, 1218.
      Schachtele, C., et al. 1988. Biochem. Biophys. Res. Commun. 151, 542.
      Kawamoto, S., and Hidaka, H. 1984. Biochem. Biophys. Res. Commun. 125, 258.

      Folleto

      Cargo
      Caspases and other Apoptosis Related Tools Brochure
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision08-January-2010 RFH
      Synonyms1-(5-Isoquinolinesulfonyl)-2-methylpiperazine, 2HCl
      DescriptionA broad-based, cell-permeable, reversible, ATP-competitive serine-threonine kinase inhibitor. Potent inhibitor of myosin light chain kinase (Ki = 97 µM), protein kinase A (Ki = 3.0 µM), protein kinase C (Ki = 6 µM), and protein kinase G (Ki = 5.8 µM). Induces apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells. Also inhibits telomerase activity in quercetin-, H-89-, or herbimycin A-treated NPC-076 cells.
      FormLight yellow lyophilized solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number108930-17-2
      Chemical formulaC₁₄H₁₇N₃O₂S · 2HCl
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityH₂O (20 mg/ml). Further dilute with aqueous buffers just prior to use.
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, store in the refrigerator (4°C). Aqueous stock solutions are stable for up to 6 months at 4°C.
      Toxicity Standard Handling
      ReferencesKu, W.-C., et al. 1997. Biochem. Biophys. Res. Commun. 241, 730.
      Jarvis, W.D., et al. 1994. Cancer Res. 54, 1707.
      Bergstrand, H., et al. 1992. J. Pharmacol. Exp. Therap. 263, 1334.
      Gimond, C., et al. 1992. Exp. Cell Res. 203, 365.
      Quick, J., et al. 1992. Biochem. Biophys. Res. Commun. 187, 657.
      Bouli, N.M., and Davis, M. 1990. Brain Res. 525, 198.
      Takahashi, I., et al. 1990. J. Pharmacol. Exp. Ther. 255, 1218.
      Schachtele, C., et al. 1988. Biochem. Biophys. Res. Commun. 151, 542.
      Kawamoto, S., and Hidaka, H. 1984. Biochem. Biophys. Res. Commun. 125, 258.

      Productos y aplicaciones relacionados

      Categorías

      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase C (PKC) Inhibitors
      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase A (PKA; cAMP-Dependent Protein Kinase) Inhibitors
      Life Science Research > Inhibitors and Biochemicals > Small Molecules & Inhibitors > Protein Phosphorylation / Dephosphorylation > Protein Kinase G (PKG; cGMP-Dependent Protein Kinase) Inhibitors